The pharmacy benefit management market provides solutions for managing prescription drug programs, optimizing formularies, and controlling healthcare costs for insurers, employers, and patients. PBMs work with pharmacies, healthcare providers, and pharmaceutical companies to simplify claims handling, increase drug availability, and improve medication compliance. For B2B decision-makers, understanding which services anchor this ecosystem is the first step toward evaluating partners and planning investments.

Market Snapshot

Polaris Market Research valued the global pharmacy benefit management market at USD 593.30 billion in 2025 and projects it will reach USD 956.95 billion by 2034, a CAGR of 5.5% from 2026 to 2034. North America was the largest regional market in 2025 with approximately 57.95% share, and the U.S. held 78% of that regional share.

Pharmacy Claims Processing: The Largest Service Segment

By service, the market is divided into specialty pharmacy services, benefit plan design and administration, pharmacy claims processing, formulary management, and others. Pharmacy claims processing led the market in 2025 and held 25.6% of global revenue share, owing to its essential role in simplifying prescription management and decreasing administrative expenses.

The function verifies, adjudicates, and reimburses prescription claims for pharmacies, insurers, and PBMs. It relies on automated claims systems and real-time adjudication, which helps reduce administrative cost and fraud. In employer healthcare benefits, it processes employee prescriptions and manages reimbursements.

Formulary Management and Cost Control

Formulary management covers the drug lists and coverage policies that determine which medications are approved and how access is controlled. The report describes its focus as cost control and drug optimization, with preferred drug lists and tiered pricing as typical examples. Insurance drug plans use it to create approved drug lists and tier-based pricing, and it reduces drug spending through formulary design. Analytics for drug selection and pricing support the function, which the report treats as an essential supporting role within PBM solutions.

Specialty Pharmacy Services: The Fastest-Growing Segment

Specialty pharmacy services handle high-cost, complex medications such as oncology drugs, biologics, and rare disease treatments. The segment is projected to grow at the fastest rate, 6.3%, due to rising demand for specialty drugs and personalized therapies. Delivery depends on advanced tracking, cold chain logistics, and patient monitoring, so cost is high but outcomes improve for chronic conditions.

Recent developments reflect this focus. In May 2025, Waltz Health and WellDyne introduced a transparent specialty pharmacy option powered by Waltz Connect for health plans and self-insured employers. In September 2025, RxBenefits added Illuminate Rx to its PBM marketplace, giving employers more flexible and cost-effective pharmacy plan options, including specialty and GLP-1 medications.

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞 :

https://www.polarismarketresearch.com/industry-analysis/pharmacy-benefit-management-market 

Benefit Plan Design and Chronic Disease Demand

Benefit plan design and administration is a distinct service segment in the report, sitting alongside the services above. Demand for all of them is reinforced by chronic disease management needs. According to the American Lung Association, over 35 million people in the U.S. have a chronic lung disease, including 26.8 million with asthma and about 11.7 million adults diagnosed with COPD.

PBMs optimize formulary strategy, track prescription use, and contain long-term therapy expenditures. They also support long-term therapies for conditions such as diabetes, asthma, and COPD with adherence programs and cost control.

Competitive Landscape and Key Players

The market is moderately competitive, with businesses concentrating on digital platforms, AI-driven analytics, and specialty pharmacy solutions. Partnerships among PBMs, insurers, and pharmacies are improving service efficiency and supporting adoption in major regions. Leading players include Evernorth Health, Inc., CVS Health, Optum, Inc., Prime Therapeutics LLC, MedImpact, Capital Rx, Inc., EmpiRx Health, LLC, Liviniti, RxSense LLC, LucyRx, CerpassRx, and Abarca Health LLC.

Strategic Takeaway

For payers, employers, and technology vendors, comparing providers by service depth is practical. Claims accuracy, formulary design, and specialty capability each address a different part of prescription cost control, and aligning them with organizational goals helps buyers select PBM solutions that fit their patient populations.

Conclusion

The Pharmacy Benefit Management Market is expected to maintain steady momentum as healthcare organizations focus on controlling prescription drug costs. Growing demand for efficient medication management and improved patient access will support market development. Technological advancements in claims processing, analytics, and personalized pharmacy services are creating new opportunities. Increasing adoption of digital healthcare platforms is further enhancing operational efficiency. Competitive strategies, regulatory developments, and evolving drug pricing models will continue to influence the market. Overall, the market outlook remains positive as stakeholders seek cost-effective and value-driven pharmacy solutions.

More Trending Latest Reports By Polaris Market Research:

Neurological Biomarkers Market

Iliac Stent Market

Halal Pharmaceuticals Market

Clindamycin Phosphate Injection Market

Iliac Stent Market

Muscle Stimulator Market

Mud Pumps Market

Stringent Regulations to Contain the Hospital Acquired Disease

Wall Art Market